Page last updated: 2024-09-05

organophosphonates and Coronary Restenosis

organophosphonates has been researched along with Coronary Restenosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coats, P; Kennedy, S; Pyne, S; Wadsworth, RM; Wainwright, CL	1

Other Studies

1 other study(ies) available for organophosphonates and Coronary Restenosis

Article	Year
Inhibition of non-Ras protein farnesylation reduces in-stent restenosis. Atherosclerosis, 2008, Volume: 197, Issue:2 Topics: Aged; Animals; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Enzyme Inhibitors; Farnesyltranstransferase; Female; Humans; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle Cells; Muscle, Smooth, Vascular; Organophosphonates; Phosphoric Acids; Platelet-Derived Growth Factor; Rabbits	2008

Article

Year

Inhibition of non-Ras protein farnesylation reduces in-stent restenosis.

Atherosclerosis, 2008, Volume: 197, Issue:2

Topics: Aged; Animals; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Enzyme Inhibitors; Farnesyltranstransferase; Female; Humans; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle Cells; Muscle, Smooth, Vascular; Organophosphonates; Phosphoric Acids; Platelet-Derived Growth Factor; Rabbits

2008